Meyer Justice

Home » Meyer Justice

conduct a large postmarket safety clinical trial.

uloric was performed in more than 6,000 patients with gout treated with either Uloric or allopurinol. The primary result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and an issue of insufficient blood supply to the heart requiring intervention, called…[Read more]

conduct a large postmarket safety clinical trial. The trial was conducted in over 6,000 patients with gout treated with either Uloric or allopurinol. The main result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of inadequate blood supply to the heart requiring intervention, called unstable…[Read more]

conduct a large postmarket safety clinical trial.

uloric was conducted in over 6,000 patients with gout treated with either Uloric or allopurinol. The main result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and an issue of insufficient blood supply to the heart requiring intervention, called unstable…[Read more]

conduct

uloric stroke . The trial was performed in over 6,000 patients with gout treated with either Uloric or allopurinol. The primary outcome was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of inadequate blood supply to the heart requiring intervention, called unstable angina.

Does…[Read more]

conduct a large postmarket safety clinical trial. The trial was conducted in more than 6,000 patients with gout treated with either Uloric or allopurinol. The primary outcome was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of inadequate blood supply to the heart requiring intervention, called…[Read more]

The U.S. Food and Drug Administration (FDA) just determined there is an enhanced risk of mortality with Uloric (febuxostat) compared to another gout medicine, allopurinol. This determination is based on our in-depth study of results from a safety clinical trial that found an increased risk of heart-related death and mortality from all causes with…[Read more]